Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17,417,453
-
Total 13F shares
-
3,718,862
-
Share change
-
+3,703,862
-
Total reported value
-
$11,617,455
-
Price per share
-
$3.12
-
Number of holders
-
26
-
Value change
-
+$11,614,005
-
Number of buys
-
26
-
Number of sells
-
1
Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) as of Q3 2023
As of 30 Sep 2023 Insight Molecular Diagnostics Inc. - Common Stock (IMDX) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,718,862 shares of stock of the company.
Largest 10 holders included BROADWOOD CAPITAL INC, PURA VIDA INVESTMENTS, LLC, VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and Tower Research Capital LLC (TRC).
This table shows 26 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.